January 17, 2024
The Biden administration and advocacy groups agreed to end a government appeal of a D.C. federal judge's decision to vacate a 2021 rule that allowed insurers to not count coupons or discounts provided by pharmaceutical companies to patients toward patients' deductibles and out-of-pocket maximums.